Amid so many crises around the world, it’s easy to forget the scale of America’s debt problem. But a new report from the Congressional Budget Office puts the stakes in sharp relief: Even under the ...
artemis II on the launchpad for dress rehearsal, far-off image - Joe Raedle/Getty Images Humanity's impending return to the moon after more than 50 years has many excited about the prospect of Artemis ...
The verdict, it seems, is in: artificial intelligence is not about to replace mathematicians. That is the immediate takeaway from the “First Proof” challenge—perhaps the most robust test yet of the ...
China is facing major tax problems, but the government isn’t being fully transparent. This video explores how tax challenges are quietly building and what it could mean for the economy. Learn why ...
Anger is a deeply human emotion that arises frequently in our lives. Often, it serves as a shield, concealing more vulnerable feelings like fear, shame, rejection, and helplessness. Many of us have a ...
Boeing just announced the end of years of deep financial losses, a turnaround for a company after nearly seven years of bad news. The US aircraft maker reported $8.2 billion in net profit in the ...
For this week’s Infinite Scroll column, Brady Brickner-Wood is filling in for Kyle Chayka. Shortly after Elon Musk purchased Twitter, in 2022, he claimed that “removing child exploitation is priority ...
MPAX is a hardware-accelerated, differentiable, batchable, and distributable solver for mathematical programming in JAX, designed to integrate with modern computational and deep learning workflows: ...
A research team from Huawei’s advanced wireless labs in Canada and China has published a blueprint for a 6G core network that can generate, update and execute its own control procedures without human ...
For many years, organizations have relied on a familiar view of the customer journey. The idea that a user moves from awareness to consideration to decision in a neat and predictable line has shaped ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...